CSV and CSA FAQs: Practical Answers for Life Sciences Validation Teams
Get practical answers about CSV, CSA, risk-based testing, assurance needs, documentation, requirements, and ValGenesis support for software validation.
Latest News
Pharma Tech Transfer FAQs: Reducing Risk, Cost, and Delays in Scale-Up
Jul 2, 2026, 9:00:00 AM | Get clear answers to common questions about pharma tech transfer, including scale-up, QbD, digital tools, and how to reduce delays, cost, and risk.
All Blog Posts
Pharma Tech Transfer FAQs: Reducing Risk, Cost, and Delays in Scale-Up
Get clear answers to common questions about pharma tech transfer, including scale-up, QbD, digital tools, and how to reduce delays, cost, and risk.
.webp){kind=spacer}
How Inefficiencies in Tech Transfer Drive Up Costs (And What to Do About It)
Discover how inefficiencies in tech transfer in pharma increase costs and delays—and how digital tools help reduce both cost and risk.
A Digital Toolbox for Effective Tech Transfer in Pharma
Discover how digital tools simplify tech transfer in Pharma 4.0, enhancing efficiency, product quality, and speed to market in the pharmaceutical industry.
Better Tech Transfers: A Digital Transformation Approach
Learn about rising drug development costs, the role of CDMOs, and how a digital-first strategy can revolutionize tech transfer in the pharma industry.
How to Accelerate Process Scale-up With Effective Tech Transfer
There's a need to accelerate pharma product development and process scale-up. Having an effective tech transfer strategy can help you.
Tech Transfer: Planning for Success
Tech Transfer is especially important. When switching facilities, you want to transfer the knowledge and reproduce the process smoothly.
All Tags
Featured Content
Quality Risk Management
Finding the Root Cause in mAB Production: a ValGenesis Story
Learn how we helped a customer find the root cause of a problem in monoclonal antibody (mAB) production and become stronger.
Written by
Sofia Santos
Tech Transfer & Process Scale-up
How to Accelerate Process Scale-Up With Effective Tech Transfer
There's a need to accelerate pharma product development and process scale-up. Having an effective tech transfer strategy can help you.
Written by
Sofia Santos
Cleaning Validation
Risk-Based Cleaning Validation: A Lifecycle Approach
Explore the evolution of pharmaceutical cleaning validation from compliance-focused practices to a risk-based, lifecycle-driven approach.
Written by
Kenneth Pierce
CSV and the Shift to CSA
CSA flips the paradigm of traditional CSV to "right-size" validation processes. Learn more about the benefits and principles of the CSA approach, which encourages critical thinking and automation.
Previously
ValConnect Innovation Day Princeton: A Glimpse into the Digital Future of Life Sciences
Catalent's Journey of Continuous Improvement for CSV Excellence
Cleaning Validation
Learn how digitization offers a consistent way to carry out cleaning validation lifecycle activities, ensuring your methods and procedures are risk-based and rooted in scientific evidence.
Cleaning Validation in Pharma: FAQs on Limits, Risk, and Control
Explore practical FAQs on cleaning validation in pharma, including regulatory expectations, limits, lifecycle stages, sampling, change control, and digital execution.
Previously
Dirty and Clean Hold Times: Setting Defensible Limits for Cleaning Validation
High-quality Content Straight to Your Inbox!
Join our newsletter to receive updates on the latest news and industry-related content tailored to your preferences.
